An exploratory mediation analysis of stroke outcomes in the REWIND CVOT, in which dulaglutide reduced systolic blood pressure (SBP) by a mean of 1.7 mmHg compared to placebo, found that the blood pressure reduction caused by dulaglutide accounts for around 14% of its effect on stroke risk [21]
Suggested Use: 1-2 softgels per day or as directed by a health professional
& Seitz, J
We aspire to be the premier research-intensive biopharmaceutical company in the world and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals
G., Vasiliu, A., Georgescu, E., and Eremia, N
GLP-1 & Muscle Loss: Evidence and Prevention GLP-1 receptor agonists such as semaglutide and liraglutide have transformed weight management for people with obesity, but concerns about muscle loss during treatment are increasingly common